Company Overview - Kanghui Co., Ltd. announced the establishment of a wholly-owned subsidiary, Kanghui Zhichuang, with a registered capital of 10 million yuan, set to be established in May 2025 [1] - To support business development and enhance financial strength, the company plans to increase its investment in Kanghui Zhichuang by 90 million yuan, raising the registered capital to 100 million yuan after the completion of the capital increase [1] Financial Performance - For the first half of 2025, Kanghui Co., Ltd.'s revenue composition is as follows: pharmaceutical manufacturing accounts for 60.68%, pharmaceutical distribution for 36.79%, and other businesses for 2.53% [1] - As of the report date, the market capitalization of Kanghui Co., Ltd. is 2.2 billion yuan [1]
康惠股份:公司拟以自有或自筹资金的方式向康惠智创增资9000万元